July 11, 2017Open Access

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

Structured PICO

Does idarucizumab safely and effectively reverse the anticoagulant effect of dabigatran in emergency situations?

Population

Patients in emergency situations requiring reversal of dabigatran

Intervention

Idarucizumab

Outcome

Reversal of the anticoagulant effect of dabigatransurrogate

Idarucizumab provides rapid, durable, and safe reversal of dabigatran anticoagulation in emergency situations.

Abstract

In emergency situations, idarucizumab rapidly, durably, and safely reversed the anticoagulant effect of dabigatran. (Funded by Boehringer Ingelheim; RE-VERSE AD ClinicalTrials.gov number, NCT02104947 .).

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Charles V. Pollack

Paul Reilly

Joanne van Ryn

Journals

New England Journal of Medicine

The Medicine Forum

Actions

Institutions

Northwestern University

Duke University

Boston University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

Structured PICO

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study